Research Article
Risk Factors for Infection with Different Hepatitis C Virus Genotypes in Southern Brazil
Table 2
Genotype distribution according to risk factors among hepatitis C virus-infected patients from the countryside of southern Brazil ( and %).
| Risk factors | N
*
| Genotype 1 | Genotype 2 | Genotype 3 | P value* |
| Blood transfusion | 397 | | | |
0.160 | Yes | | 50 (36.5) | 33 (24.1) | 54 (39.4) | No | | 118 (45.4) | 46 (17.7) | 96 (36.9) |
| Use of IV medication | 393 | | | |
0.199 | Yes | | 68 (41.7) | 39 (23.9) | 56 (34.4) | No | | 95 (41.3) | 40 (17.4) | 95 (41.3) |
| Acupuncture | 393 | | | |
0.726 | Yes | | 4 (30.8) | 3 (23.1) | 6 (46.2) | No | | 163 (41.5) | 79 (20.1) | 151 (38.4) |
| Hemodialysis | 390 | | | |
0.510 | Yes | | 4 (30.8) | 2 (15.4) | 7 (53.8) | No | | 157 (41.6) | 77 (20.4) | 143 (37.9) |
| Exposure to blood or organic secretions | 391 | | | |
0.119 | Yes | | 26 (31.7) | 19 (23.2) | 37 (45.1) | No | | 137 (44.3) | 58 (18.8) | 114 (36.9) |
| Tatoo | 393 | | | |
0.207 | Yes | | 25 (46.3) | 6 (11.1) | 23 (42.6) | No | | 138 (40.7) | 73 (21.5) | 128 (37.8) |
| Use of injection drugs | 394 | | | |
0.032 | Yes | | 38 (53.5) | 7 (9.9) | 26 (36.6) | No | | 129 (39.9) | 71 (22.0) | 123 (38.1) |
| Surgical treatment | 393 | | | |
0.023 | Yes | | 81 (39.5) | 52 (25.4) | 72 (35.1) | No | | 82 (43.6) | 27 (14.4) | 79 (42.0) |
| Piercing | 393 | | | |
0.643 | Yes | | 4 (40.0) | 1 (10.0) | 5 (50.0%) | No | | 159 (41.5) | 78 (20.4) | 146 (38.1) |
| Inhalation drug | 389 | | | |
0.028 | Yes | | 32 (53.3) | 5 (8.3) | 23 (38.3) | No | | 130 (39.5) | 73 (22.2) | 126 (38.3) |
| Dental procedure | 394 | | | |
0.010 | Yes | | 72 (36.7) | 51 (26.0) | 73 (37.2) | No | | 92 (46.5) | 28 (14.1) | 78 (39.4) |
| Transplant | 391 | | | |
0.287 | Yes | | 1 (25.0) | 0 (0.0) | 3 (75.0) | No | | 161 (41.6) | 79 (20.4) | 147 (38.0) |
| Percutaneous accident | 389 | | | |
0.979 | Yes | | 7 (43.8) | 3 (18.8) | 6 (37.5) | No | | 154 (41.3) | 75 (20.1) | 144 (38.6) |
|
|
-square test; IV: intravenous.
|